학술논문
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
Document Type
Article
Author
Ragni, M.V.; Rothenberger, S.D.; Feldman, R.; Seaman, C.; Machin, N.; Smith, K.J.; Koerbel, G.; Althouse, A.D.; Xavier, F.; Ivanco, D.; Vehec, D.; Nance, D.; Leavitt, A.D.; Malec, L.; Kulkarni, R.; Sidonio, R.; Kraut, E.; Lasky, J.; Pruthi, R.; Angelini, D.; Philipp, C.; Hwang, N.; Wheeler, A.P.; Meyer, M.; Bellissimo, D.; Humphreys, G.; Merricks, E.P.; Nichols, T.C.
Source
In: The Lancet Haematology . (The Lancet Haematology, August 2023, 10(8):e612-e623)
Subject
Language
English
ISSN
23523026